Dogwood Therapeutics
DWTX
12 hedge funds and large institutions have $300K invested in Dogwood Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
44% more capital invested
Capital invested by funds: $208K → $300K (+$92K)
20% more funds holding
Funds holding: 10 → 12 (+2)
0.23% less ownership
Funds ownership: 2.26% → 2.04% (-0.23%)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.3K |
| 3 |
Citigroup
New York
|
+$493 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$50 |
| 5 |
Barclays
London,
United Kingdom
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$83.9K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
-$756 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$239 |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$114 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $171K | +$51.7K | +10,397 | +88% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $116K | +$11.3K | +2,261 | +18% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $5.73K | -$239 | -48 | -6% |
|
|
4
Morgan Stanley
New York
| $4.62K | -$83.9K | -16,850 | -97% |
|
|
AWM
5
Activest Wealth Management
Aventure,
Florida
| $924 | – | – | – |
|
|
6
Citigroup
New York
| $762 | +$493 | +99 | New |
|
7
BlackRock
New York
| $231 | – | – | – |
|
|
8
Bank of America
Charlotte,
North Carolina
| $123 | -$5 | -1 | -6% |
|
|
9
BNP Paribas Financial Markets
Paris,
France
| $77 | +$50 | +10 | New |
|
10
Group One Trading
Chicago,
Illinois
| $69 | – | – | – |
|
|
11
Barclays
London,
United Kingdom
| $39 | +$25 | +5 | New |
|
|
SS
12
SBI Securities
Tokyo,
Japan
| $8 | -$756 | -152 | -99% |
|
|
13
Raymond James Financial
St Petersburg,
Florida
| – | -$114 | -24 | Closed |
|
DWTX Hedge Fund Activity: Q3 2025 in Review
12 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q3 2025, worth a combined $300K — up 44% from $208K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DWTX positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $51.7K. The largest seller was Morgan Stanley, cutting an estimated $83.9K.
- 12 institutional investors held Dogwood Therapeutics (DWTX) as of Q3 2025, up from 10 in Q2 2025.
- Funds reported $300K of Dogwood Therapeutics stock for Q3 2025, up 44% quarter-over-quarter.
- 3 funds opened new Dogwood Therapeutics positions in Q3 2025 and 1 closed out, a net change of +2 holders.
- The largest Dogwood Therapeutics buyer in Q3 2025 was Vanguard Group, an estimated $51.7K added.
- The largest Dogwood Therapeutics seller in Q3 2025 was Morgan Stanley, an estimated $83.9K sold.
Based on aggregated 13F filings for Q3 2025.